Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Midazolam Versus Intranasal Ketamine to Sedate Newborns for Intubation in Delivery Room.

NCT01517828 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT01517828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01517828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Midazolam Versus Intranasal Ketamine to Sedate Newborns for Intubation in Delivery Room.
Lead sponsor
University Hospital, Montpellier
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2012
Completion date
May 31, 2016
Enrollment
62 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prematurity of fetus, respiratory distress syndrome